FORM 4
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934,
Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f)
of the Investment Company Act of 1940.
[ ] Check box if no longer subject of Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
_______________________________________________________________________________
1. NAME AND ADDRESS OF REPORTING PERSON:
Jensen James U.
----------------------------------------------------------------------
(Last) (First) (Middle)
44 North Wolcott
----------------------------------------------------------------------
(Street)
Salt Lake City, Utah 84103
----------------------------------------------------------------------
(City) (State) (Zip)
_______________________________________________________________________________
2. ISSUER NAME AND TICKER OR TRADING SYMBOL
Interwest Home Medical, Inc. - IWHM
_______________________________________________________________________________
3. IRS OR SOCIAL SECURITY NUMBER OF REPORTING PERSON (Voluntary)
_______________________________________________________________________________
<PAGE>
_______________________________________________________________________________
4. Statement for Month/Year
February, 2000
_______________________________________________________________________________
5. If Amendment, Date of Original (Month/Year)
N/A
_______________________________________________________________________________
6. RELATIONSHIP OF REPORTING PERSON(S) TO ISSUER - Check all applicable
__X__ Director _____ 10% Owner
_____ Officer (give title _____ Other (specify below)
below)
===============================================================================
TABLE 1 - NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
_______________________________________________________________________________
1. Title of Security (Instr. 3)
Interwest Home Medical, Inc. - Common Stock
_______________________________________________________________________________
2 Transaction Date - (Month/Day/Year)
_______________________________________________________________________________
3. Transaction Code - (Instr. 8)
Code V
------------
_______________________________________________________________________________
4. Secutities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)
Amount (A) or (D) Price
_______________________________________________________________________________
5. Amount of Securities, Beneficially Owned at End of Month
(Instr. 3 and 4)
114,424
_______________________________________________________________________________
6. Ownership Form - Direct (D) or Indirect (I) - (Instr. 4)
D
_______________________________________________________________________________
7. Nature of Indirect Beneficial Ownership - (Instr. 4)
N/A
_______________________________________________________________________________
TABLE II - DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED
(e.g. puts, calls, warrants, options, convertible securities)
_______________________________________________________________________________
1. Title of Derivative Security - (Instr. 3)
Stock Option - Right to Buy
_______________________________________________________________________________
2. Converstion or Exervice Price of Derivative Security
_______________________________________________________________________________
3. Transaction Date - (Momth/Day/Year)
12/13/99
_______________________________________________________________________________
4. Transaction Code (Instr. 8)
Code V
------------
J
_______________________________________________________________________________
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr.3,
4 and 5)
(A) (D)
40,000
_______________________________________________________________________________
6. Date Exercisable and Expiration Date: (Month/Day/Year)
Date Exercisable Expiration Date
See "A" Below in
Explanation of Responses
______________________________________________________________________________
7. Title and Amount of Underlying Securities - (Instr. 3 and 4)
Title Amount or Number of Shares
Common Stock 40,000
_______________________________________________________________________________
8. Price of Derivative Security (Instr. 5)
$3.00
_______________________________________________________________________________
9. Number of Derivative Securities Beneficially Owned at End of Month
(Instr. 4)
91,500
_______________________________________________________________________________
10. Ownership Form of Derivative Security; Direct (D) or Indirect (I) -
(Instr. 4)
D
_______________________________________________________________________________
11. Nature of Indirect Beneficial Onwerhsip (Instr. 4)
N/A
_______________________________________________________________________________
Explanation of Responses:
A. All previous options granted with 5-year expiration extended to 10-year
expiration:
1. 4/1/97 - Grant of 40,000 shares @ $4.00 per share, new termination date
is 3/31/07.
2. 2/24/95 - Grant of 5,000 shares @ $5.52 per share, new termination date
is 2/23/05.
3. 4/1/96 - Grant of 1,500 shares @ $4.75 per share, new termination date
is 3/31/06.
4. 9/30/97 - Grant of 33,000 shares @ $4.28-5.50 per share, new termination
date is 9/29/07.
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, See Instruction 6 for procedure.
Date: March 8, 2000 /s/ James U. Jensen
--------------------------------
**Signature of Reporting Person
